Drugs / PRO-232
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07305987 | Oct 2025 → Jun 2026 overdue | cataract | Laboratorios Sophia S.A de C.V. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-232 | “The main objective of this study is to evaluate the efficacy and safety of the PRO-232 formulation manufactured by Laboratorios Sophia S.A. de C.V. on the ocular surface of...” NCT07305987 ↗ |
| Route | Topical | “PRO-232 ophthalmic solution applied to the ocular surface of postoperative cataract patients” NCT07305987 ↗ |